<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">100892005</journal-id><journal-id journal-id-type="pubmed-jr-id">21821</journal-id><journal-id journal-id-type="nlm-ta">J Acquir Immune Defic Syndr</journal-id><journal-id journal-id-type="iso-abbrev">J Acquir Immune Defic Syndr</journal-id><journal-title-group><journal-title>Journal of acquired immune deficiency syndromes (1999)</journal-title></journal-title-group><issn pub-type="ppub">1525-4135</issn><issn pub-type="epub">1944-7884</issn></journal-meta><article-meta><article-id pub-id-type="pmid">39940067</article-id><article-id pub-id-type="pmc">12070293</article-id><article-id pub-id-type="doi">10.1097/QAI.0000000000003650</article-id><article-id pub-id-type="manuscript">HHSPA2063661</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Behavioral Readiness for Daily Oral PrEP in a Diverse Sample of Gay,
Bisexual, and Other Men who have Sex with Men Who Have Not Been Offered PrEP by
a Provider</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kota</surname><given-names>Krishna Kiran</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Mansergh</surname><given-names>Gordon</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Carnes</surname><given-names>Neal</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Gelaude</surname><given-names>Deborah</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of HIV Prevention, National Center for HIV, Viral
Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention,
Atlanta, GA, USA</aff><author-notes><corresp id="CR1"><bold>Corresponding Author:</bold> Krishna Kiran Kota, PhD, MS,
Division of HIV Prevention, Centers for Disease Control and Prevention, 1600
Clifton Road, NE, MS H18-3, Atlanta, Georgia 30333,
<email>qel3@cdc.gov</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>8</day><month>3</month><year>2025</year></pub-date><pub-date pub-type="ppub"><day>01</day><month>6</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>6</month><year>2025</year></pub-date><volume>99</volume><issue>2</issue><fpage>123</fpage><lpage>127</lpage><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P1">Daily oral pre-exposure prophylaxis (PrEP) use among gay, bisexual,
and other men who have sex with men (GBMSM) remains suboptimal. Assessing
behavioral readiness for PrEP use among GBMSM who can benefit and offering
PrEP may increase uptake among GBMSM. We measured 4-item readiness for
taking PrEP among GBMSM who have not been offered PrEP by a provider.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">GBMSM in Atlanta, Chicago, and Raleigh-Durham reporting recent
condomless anal sex were assessed for &#x0201c;readiness&#x0201d; to discuss
PrEP with a provider, test for HIV, take a daily pill, attend provider
appointments, and a 4-component composite score for PrEP readiness.
Chi-square tests and multivariable logistic regression were applied to
examine factors associated with readiness to use PrEP.</p></sec><sec id="S3"><title>Results:</title><p id="P3">Study sample (n=187) was 51% Black/African American, 15%
Hispanic/Latino, 30% identified as bisexual or straight or other, and 29%
had no health insurance. 55% said they were ready to discuss PrEP with a
provider, 88% were ready to get an HIV test, 45% were ready to take a daily
pill, 48% were ready to attend appointments, and 37% reported overall PrEP
readiness. Having no health insurance was associated with readiness for a
daily pill (AOR=2.78, CI=1.34&#x02013;5.78) and 4-item PrEP readiness
(AOR=2.34, CI=1.13&#x02013;4.85). Self-identification as gay (vs
bisexual/straight) was associated with readiness to discuss PrEP (AOR=2.14,
CI=1.05&#x02013;4.36).</p></sec><sec id="S4"><title>Conclusion:</title><p id="P4">Only 37% of GBMSM with recent condomless anal sex were ready for PrEP
based on the 4-item readiness. Readiness may differ based on sexual
identity, insurance status, and other characteristics. Efforts are needed to
increase readiness across behavioral components of PrEP use.</p></sec></abstract></article-meta></front><body><sec id="S5"><title>Introduction</title><p id="P5">Daily oral HIV pre-exposure prophylaxis (daily PrEP) has been available in
the United States since 2012 and PrEP use has increased over the last
decade.<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup> However, PrEP use remains suboptimal among
gay, bisexual, and other men who have sex with men (GBMSM) who could
benefit.<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref></sup> Factors associated with the lower uptake of
daily PrEP among GBMSM are multifaceted, including knowledge, attitudes, beliefs,
and concerns about side effects at an individual-level, negative experiences with
healthcare providers, PrEP-related stigma, and PrEP norms in sexual and social
networks at a community-level, and high out-of-pocket expenses and lack of insurance
coverage at a policy-level.<sup><xref rid="R5" ref-type="bibr">5</xref>&#x02013;<xref rid="R7" ref-type="bibr">7</xref></sup></p><p id="P6">Individual-level factors associated with daily PrEP use play an important
role, in particular, among GBMSM who could benefit from PrEP use and were not
offered PrEP by a provider. Among this unique group of GBMSM, some men might be
ready for PrEP use if they are offered by a provider and some men may not be ready
for daily PrEP use.<sup><xref rid="R8" ref-type="bibr">8</xref>&#x02013;<xref rid="R10" ref-type="bibr">10</xref></sup> Offering PrEP to all GBMSM who can
benefit from PrEP is recommended by the CDC&#x02019;s PrEP guidelines and is critical
to increase PrEP uptake.<sup><xref rid="R11" ref-type="bibr">11</xref></sup> While
there are studies that assessed the willingness and readiness for PrEP among GBMSM
with indications for PrEP use,<sup><xref rid="R12" ref-type="bibr">12</xref></sup>
to our knowledge there were no studies that focused on readiness for PrEP among men
who have not been offered PrEP by a provider. Identifying GBMSM who are ready to
take daily PrEP and offering it to them could lead to PrEP initiation.<sup><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R13" ref-type="bibr">13</xref></sup> PrEP readiness is
more complex than simply accepting it when offered by a provider and includes
motivational and attitudinal beliefs about discussing PrEP with the provider,
getting tested for HIV, following a daily pill regimen, and ability to attend
medical appointments at regular intervals.<sup><xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R15" ref-type="bibr">15</xref></sup></p><p id="P7">Assessing the overall readiness for daily oral PrEP among individuals with
indications for PrEP and have not been offered PrEP by a provider, may provide an
opportunity to identify men who are more likely to use daily oral PrEP and increase
prescribing PrEP by providers. In this study, we measured and examined the factors
associated with 4-item readiness for a daily oral PrEP among GBMSM who could benefit
from PrEP use and who haven&#x02019;t been offered PrEP by a provider.</p></sec><sec id="S6"><title>Methods</title><p id="P8">Data for this analysis were derived from the 2019 iQual Prepare for PrEP
Study conducted to examine the PrEP related outcomes and associated behavioral
factors among GBMSM in Atlanta, Chicago, and Raleigh-Durham.<sup><xref rid="R16" ref-type="bibr">16</xref></sup> Study participants were recruited at events
sponsored and hosted by partner community-based organizations, local agencies, and
health clinics in Atlanta, Chicago, and Raleigh-Durham. Participants completed the
in-person self-administered eligibility screener at the study sites. All eligible
participants completed the in-person self-administered computer based behavioral
assessment immediately at the study sites. Eligibility criteria included
self-reported HIV-negative status or unknown or never tested; male; 18 years of age
or older; report condomless anal sex (without PrEP use) with a male partner in the
past six months; not offered PrEP by a provider or counselor in the past six months;
and resided in Chicago, Raleigh-Durham, or Atlanta at the time of data
collection.</p><p id="P9">Readiness for daily oral PrEP was assessed by the 4 key items focused on
discussing PrEP with provider, HIV testing, taking daily pill, and attending
appointments as:</p><p id="P10">If you were to start taking PrEP today, how ready would you be to do each of
the following actions:</p><list list-type="order" id="L2"><list-item><p id="P11">Meet with a doctor or other provider to discuss PrEP.</p></list-item><list-item><p id="P12">Get tested for HIV infection.</p></list-item><list-item><p id="P13">Take a PrEP pill every day for the next few months.</p></list-item><list-item><p id="P14">Attend monitoring appointments with a doctor or other provider every
few months.</p></list-item></list><p id="P15">The response options for the 4 items were recorded on a 5-point Likert scale
(1 - Not at all ready, 2 - A little ready, 3 -Somewhat ready, 4 - Mostly ready, 5 -
Entirely ready). For each item, participants were considered &#x0201c;ready&#x0201d;
if they responded with &#x0201c;mostly ready&#x0201d; and &#x0201c;entirely
ready.&#x0201d; For the 4-component composite score for full regimen, participants
who responded with &#x0201c;mostly ready&#x0201d; and &#x0201c;entirely ready&#x0201d;
for all 4 items.</p></sec><sec id="S7"><title>Data analysis</title><p id="P16">We conducted chi-square tests to examine the bivariate associations between
the demographic characteristics (age, race and ethnicity, education, sexual
identity, and health insurance status) and the four separate readiness components
and the overall readiness for daily oral PrEP. Multivariable logistic regression
models were conducted to assess the independent associations between the demographic
characteristics and the readiness for daily oral PrEP (separate models for four
individual components and overall readiness). All models were adjusted for the
sociodemographic characteristics of race/ethnicity, age group, education level,
sexual identity, and health insurance status. All data analyses were performed by
using SAS<sup>&#x000a9;</sup> 9.4. Study procedures were approved and monitored by
the CDC Institutional Review Board (Protocol #7031).</p></sec><sec id="S8"><title>Results</title><p id="P17">The study sample consisted of 51% Black/African American, 15%
Hispanic/Latino, and 34% White or Other GBMSM. Seventy percent of the men identified
as gay, 21% as bisexual, 4% as straight, and 5% as other (bisexual or straight).
Nearly one-third (31%) were in the age-group of 18&#x02013;25 years, 41% were in
26&#x02013;35 years, and 28% were 36 years or older. Forty-two percent reported
having at least a 4-year college degree, 26% had some post high school training, and
31% reported having high school/general education degree. Twenty-nine percent
reported not having a health insurance coverage.</p><p id="P18">Fifty-five percent of the sample were ready to discuss daily oral PrEP with
a provider, 88% were ready to get an HIV test, 45% were ready to take a daily pill,
and 48% were ready to attend appointments. Based on the composite score of the four
items that measured readiness, 37% of the sample indicated overall PrEP readiness.
In bivariate analysis (<xref rid="T1" ref-type="table">Table 1</xref>), a 3-level
education variable was associated with overall PrEP readiness (&#x003c7;2 = 7.22, p =
0.027). Self-identified sexuality as gay (vs bisexual or straight) was associated
with readiness to discuss daily oral PrEP with a provider (&#x003c7;2 = 5.15, p =
0.023) and readiness to get an HIV test (&#x003c7;2 = 4.12, p = 0.042). Having no
health insurance (having health insurance) was associated with readiness to take a
daily oral pill (&#x003c7;2 = 9.36, p = 0.002), to attend appointments (&#x003c7;2 =
4.07, p = 0.044), and overall PrEP readiness (&#x003c7;2 = 8.45, p = 0.004).</p><p id="P19">In multivariable regression analysis for each PrEP-related behavior and
overall readiness (<xref rid="T2" ref-type="table">Table 2</xref>), GBMSM who did
not have health insurance reported greater odds of readiness to take a daily oral
pill (AOR=2.78, CI = 1.34&#x02013;5.78) and overall PrEP readiness (AOR=2.34,
CI=1.13&#x02013;4.85), compared to men who had health insurance. GBMSM who identified
as gay had greater odds of readiness to discuss PrEP with a provider (AOR=2.14,
CI=1.05&#x02013;4.36), compared to men who identified as bisexual or straight. GBMSM
with some post high school training had greater odds of overall PrEP readiness (AOR
= 2.34, CI = 1.04&#x02013;5.29), compared to those with a 4-year degree or
higher.</p></sec><sec id="S9"><title>Discussion</title><p id="P20">Only 37% of GBMSM who reported recent condomless anal sex and who were not
offered PrEP by a provider in the past 6 months, indicated they were mostly or
entirely ready for PrEP based on a 4-item behavioral readiness assessment. Of the
necessary four behaviors to taking PrEP, readiness to get an HIV test was highest
(88%), while readiness to discuss PrEP with a provider (55%), take a daily pill
(45%), and attend appointments (48%) were lower. The 4-item PrEP readiness tool
could be used as a low-cost prevention tool with less administrative burden in
clinical and non-clinical settings to assess for readiness of PrEP uptake among men
who can benefit from PrEP use.</p><p id="P21">The study finding that men who do not have health insurance coverage
reported higher readiness to take a daily oral pill and overall PrEP readiness was
unique. There is indeed an interest and readiness for PrEP use among GBMSM with no
insurance, which calls for discussions about PrEP and offering PrEP to men without
insurance as well. A meta-analysis focused on PrEP use willingness found that health
insurance was not significantly associated with willingness to PrEP use among
GBMSM.<sup><xref rid="R12" ref-type="bibr">12</xref></sup> A possible reason
that explains this finding is that these men have the awareness of the financial
assistance programs that reduce the cost of PrEP uptake.<sup><xref rid="R12" ref-type="bibr">12</xref></sup> Regardless, this finding supports expanding
health insurance coverage and providing financial assistance as strategies to
increase PrEP uptake. The finding of not having insurance not significantly
associated with the readiness to discuss PrEP with a provider, attend appointments,
and HIV testing could be because these three behaviors (compared to taking daily
pill) might be impacted by the PrEP-related service fees including provider visits
and HIV tests.<sup><xref rid="R12" ref-type="bibr">12</xref></sup> Further, men
without health insurance may also experience unstable employment, which could impact
the ability to make appointments and get HIV testing due to the associated expenses.
There is need for more research to examine how health insurance impacts overall and
individual components of readiness for PrEP. Men who self-identified as gay (vs
bisexual or straight) were more ready to discuss PrEP with a provider. Current PrEP
messaging is geared towards self-identified and culturally integrated GBMSM which
could have led to normalization of discussions about PrEP among this community.
However, PrEP messaging focused on and in the forums where GBMSM who identify as
bisexual or straight engage, might be needed to increase PrEP readiness among these
men.</p><p id="P22">Among GBMSM who can benefit from PrEP, there may be several groups of men
based on the assessment of behavioral readiness for PrEP use. One such group is men
who are ready to use PrEP if they are offered it by a provider. Another group is men
who, overall, indicate they are not behaviorally ready to use PrEP. For men who have
lower readiness, the priority remains to increase readiness on all four components.
These men may have awareness, knowledge, and even interest in PrEP; however, those
factors are not enough for successful PrEP uptake. Readiness for key required
behaviors is also important for PrEP use. For GBMSM with lower PrEP readiness,
additional counseling and discussions focused on existing risk behavior and PrEP
benefits may increase readiness for PrEP uptake. In our sample, higher readiness for
getting an HIV test indicate some success of the current messaging and reducing
barriers for testing among GBMSM. However, lower readiness to discuss PrEP with a
provider, to take a daily pill, and to attend appointments highlight the need for
messaging and addressing the barriers specific to these components of readiness. For
men who are ready to use PrEP if offered, it might be critical to increase PrEP
prescribing by healthcare providers. Nearly one-third of participants in our study
were ready for daily oral PrEP, who may have accepted PrEP if their healthcare
providers had offered. Reasons for not offering PrEP by health care providers
include inadequate knowledge and awareness about PrEP among providers,
&#x0201c;purview paradox&#x0201d; where some providers believe other specialized
providers are better equipped to prescribe PrEP, and provider&#x02019;s concern about
&#x0201c;risk compensation&#x0201d; (using PrEP might increase the behaviors that
increase HIV risk).<sup><xref rid="R6" ref-type="bibr">6</xref></sup> Efforts are
needed to increase awareness of the PrEP guidelines and the risks and benefits of
PrEP use among providers and address the barriers for PrEP prescription. Educational
interventions, like professional detailing, were effective in improving the beliefs
about PrEP safety among healthcare providers.<sup><xref rid="R17" ref-type="bibr">17</xref>,<xref rid="R18" ref-type="bibr">18</xref></sup></p><p id="P23">Our study sample was diverse with nearly two-thirds of participants from
racial and ethnic minority groups; however, the study findings may have limited
generalizability as we used convenience sampling from three US cities. PrEP
readiness tool used in this study is limited to measuring only 4 aspects of
behavioral readiness and it was not validated, which are limitations for this study.
The small sample size of this study may have limited our analysis in detecting some
significant associations. Our findings are only focused on the readiness for daily
oral PrEP use given the limited availability of PrEP modalities and recommendations
given at the time of the study, and daily oral PrEP is the most used PrEP option in
the US.<sup><xref rid="R19" ref-type="bibr">19</xref></sup> However, our findings
may not be applicable to newer PrEP options such as event-driven (2&#x02013;1-1
dosing) and long-acting injectable PrEP.</p></sec><sec id="S10"><title>Conclusions</title><p id="P24">Findings from this study that assessed the overall behavioral readiness for
daily oral PrEP among GBMSM who can benefit from PrEP use found a lower overall
readiness for PrEP use. Higher readiness to get an HIV test for PrEP prescription is
encouraging, however, the lower readiness to discuss with a provider, to take a
daily pill, and to attend appointments highlights the need for tailored PrEP
messaging and addressing the barriers to increase readiness. Surprisingly, men
without insurance had greater odds of readiness, indicating the need to offer PrEP
to all GBMSM who can benefit regardless of their insurance status. The 4-item PrEP
readiness tool may be used routinely to identify men who are motivated to start PrEP
use when offered by a healthcare provider. Offering PrEP to these men may address an
individual-level barrier and can increase PrEP uptake and might help to achieve EHE
goals.<sup><xref rid="R20" ref-type="bibr">20</xref></sup></p></sec></body><back><ack id="S11"><title>Funding Details:</title><p id="P25">This work was supported by the U.S. Centers for Disease Control and
Prevention, under Contract No. 200-2013-57341.</p></ack><fn-group><fn id="FN1"><p id="P26"><bold>CDC Disclaimer:</bold> The findings and conclusions in this report
are those of the authors and do not necessarily represent the official position
of the Centers for Disease Control and Prevention.</p></fn><fn fn-type="COI-statement" id="FN2"><p id="P27"><bold>Conflicts of Interest:</bold> The authors have no conflicts of
interest to declare.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="webpage"><collab><ext-link xlink:href="https://HIV.gov" ext-link-type="uri">HIV.gov</ext-link></collab>. <source>FDA approves first drug for reducing the risk of sexually acquired HIV infection</source>. <month>July</month>
<day>16</day>, <year>2012</year>. <comment>Available at</comment>:
<comment><ext-link xlink:href="https://www.hiv.gov/blog/fda-approves-first-drug-for-reducing-the-risk-of-sexually-acquired-hiv-infection" ext-link-type="uri">https://www.hiv.gov/blog/fda-approves-first-drug-for-reducing-the-risk-of-sexually-acquired-hiv-infection</ext-link>.</comment>
<comment>Accessed</comment>
<date-in-citation>June 12, 2024</date-in-citation>.</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><name><surname>Finlayson</surname><given-names>T</given-names></name>, <name><surname>Cha</surname><given-names>S</given-names></name>, <name><surname>Xia</surname><given-names>M</given-names></name>, <etal/>
<article-title>Changes in HIV Preexposure Prophylaxis Awareness and Use Among
Men Who Have Sex with Men &#x02013; 20 Urban Areas, 2014 and
2017</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>.
<year>2019</year>;<volume>68</volume>(<issue>27</issue>):<fpage>597</fpage>&#x02013;<lpage>603</lpage>.<pub-id pub-id-type="pmid">31298662</pub-id>
</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="webpage"><collab>Centers for Disease Control and
Prevention</collab>. <source>Monitoring selected national HIV prevention and care Objectives by using HIV surveillance data-United States and 6 dependent areas, 2020</source>. <comment>HIV Surveillance Supplemental Report
2022.</comment>
<comment>Available at</comment>: <comment><ext-link xlink:href="https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-vol-26-no-2.pdf" ext-link-type="uri">https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-vol-26-no-2.pdf</ext-link>.</comment>
<comment>Accessed</comment>
<date-in-citation>June 12, 2024</date-in-citation>.</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Pitasi</surname><given-names>MA</given-names></name>, <name><surname>Beer</surname><given-names>L</given-names></name>, <name><surname>Cha</surname><given-names>S</given-names></name>, <etal/>
<article-title>Vital Signs: HIV Infection, Diagnosis, Treatment, and Prevention
Among Gay, Bisexual, and Other Men Who Have Sex with Men &#x02014; United
States, 2010&#x02013;2019</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>.
<year>2021</year>;<volume>70</volume>(<issue>48</issue>):<fpage>1669</fpage>&#x02013;<lpage>1675</lpage>.<pub-id pub-id-type="pmid">34855721</pub-id>
</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Bonacci</surname><given-names>RA</given-names></name>, <name><surname>Smith</surname><given-names>DK</given-names></name>, <name><surname>Ojikutu</surname><given-names>BO</given-names></name>. <article-title>Toward Greater Pre-exposure Prophylaxis Equity:
Increasing Provision and Uptake for Black and Hispanic/Latino Individuals in
the U.S.</article-title>
<source>Am J Prev Med</source>. <year>2021</year>;<volume>61</volume>(<issue>5
Suppl
1</issue>):<fpage>S60</fpage>&#x02013;<lpage>S72</lpage>.<pub-id pub-id-type="pmid">34686293</pub-id>
</mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Mayer</surname><given-names>KH</given-names></name>, <name><surname>Agwu</surname><given-names>A</given-names></name>, <name><surname>Malebranche</surname><given-names>D</given-names></name>. <article-title>Barriers to the Wider Use of Pre-exposure Prophylaxis in
the United States: A Narrative Review</article-title>. <source>Adv Ther</source>.
<year>2020</year>;<volume>37</volume>(<issue>5</issue>):<fpage>1778</fpage>&#x02013;<lpage>1811</lpage>.<pub-id pub-id-type="pmid">32232664</pub-id>
</mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Kota</surname><given-names>KK</given-names></name>, <name><surname>Mansergh</surname><given-names>G</given-names></name>, <name><surname>Stephenson</surname><given-names>R</given-names></name>, <etal/>
<article-title>Sociodemographic Characteristics of HIV Pre-Exposure Prophylaxis
Use and Reasons for Nonuse Among Gay, Bisexual, and Other Men Who Have Sex
with Men from Three US Cities</article-title>. <source>AIDS Patient Care and STDs</source>.
<year>2021</year>;<volume>35</volume>(<issue>5</issue>):<fpage>158</fpage>&#x02013;<lpage>166</lpage>.<pub-id pub-id-type="pmid">33901403</pub-id>
</mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Rolle</surname><given-names>CP</given-names></name>, <name><surname>Rosenberg</surname><given-names>ES</given-names></name>, <name><surname>Siegler</surname><given-names>AJ</given-names></name>, <etal/>
<article-title>Challenges in translating PrEP interest into uptake in an
observational study of Young Black MSM</article-title>. <source>J Acquir Immune Defic Syndr</source>. <volume>76</volume>(<issue>3</issue>),
<fpage>250</fpage>&#x02013;<lpage>258</lpage>.<pub-id pub-id-type="pmid">28708811</pub-id>
</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>Kota</surname><given-names>KK</given-names></name>, <name><surname>Gelaude</surname><given-names>D</given-names></name>, <name><surname>Carnes</surname><given-names>N</given-names></name>, <etal/>
<article-title>Low Self-Perceived Need for PrEP and Behavioral Indications of
MSM Who Recently Refused Daily PrEP: A Mixed Methods Study in Three U.S.
Cities</article-title>. <source>AIDS Behav</source>.
<year>2024</year>;<volume>28</volume>(<issue>6</issue>):<fpage>1845</fpage>&#x02013;<lpage>1857</lpage>.<pub-id pub-id-type="pmid">38457051</pub-id>
</mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>W</given-names></name>, <name><surname>Lockard</surname><given-names>A</given-names></name>, <name><surname>Kelley</surname><given-names>CF</given-names></name>, <etal/>
<article-title>From declining PrEP to PrEP initiation as &#x0201c;first
nature&#x0201d; - what changes PrEP initiation decisions among young, Black
MSM</article-title>. <source>AIDS Care</source>.
<year>2021</year>:<fpage>1</fpage>&#x02013;<lpage>10</lpage>.</mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="webpage"><collab>Centers for Disease Control and
Prevention: US Public Health Service</collab>. <source>Preexposure prophylaxis for the prevention of HIV infection in the United States&#x02014;2021 Update: A clinical practice guideline</source>.
<year>2021</year>. <comment>Available at</comment>: <comment><ext-link xlink:href="https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf" ext-link-type="uri">https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf</ext-link>.</comment>
<comment>Accessed</comment>
<date-in-citation>June 12, 2024</date-in-citation>.</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Kamitani</surname><given-names>E</given-names></name>, <name><surname>Wichser</surname><given-names>ME</given-names></name>, <name><surname>Mizuno</surname><given-names>Y</given-names></name>, <name><surname>DeLuca</surname><given-names>JB</given-names></name>, <name><surname>Higa</surname><given-names>DH</given-names></name>. <article-title>What Factors Are Associated With Willingness to Use HIV
Pre-exposure Prophylaxis (PrEP) Among U.S. Men Who Have Sex With Men Not on
PrEP? A Systematic Review and Meta-analysis</article-title>. <source>J Assoc Nurses AIDS Care</source>.
<year>2023</year>;<volume>34</volume>(<issue>2</issue>):<fpage>135</fpage>&#x02013;<lpage>145</lpage>.<pub-id pub-id-type="pmid">36563302</pub-id>
</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Nunn</surname><given-names>AS</given-names></name>, <name><surname>Brinkley-Rubinstein</surname><given-names>L</given-names></name>, <name><surname>Oldenburg</surname><given-names>CE</given-names></name>, <etal/>
<article-title>Defining the HIV pre-exposure prophylaxis care
continuum</article-title>. <source>AIDS</source>.
<year>2017</year>;<volume>31</volume>(<issue>5</issue>):<fpage>731</fpage>&#x02013;<lpage>734</lpage>.<pub-id pub-id-type="pmid">28060019</pub-id>
</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>Beauchamp</surname><given-names>G</given-names></name>, <name><surname>Hosek</surname><given-names>S</given-names></name>, <name><surname>Donnell</surname><given-names>DJ</given-names></name>, <etal/>
<article-title>Development of a tool to assess HIV prevention readiness of
adolescent girls and young women in HPTN 082 study</article-title>.
<source>PLoS One</source>.
<year>2023</year>;<volume>18</volume>(<issue>2</issue>):<fpage>e0281728</fpage>.
doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0281728</pub-id><pub-id pub-id-type="pmid">36827440</pub-id>
</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Fernandez</surname><given-names>MI</given-names></name>, <name><surname>Hosek</surname><given-names>S</given-names></name>, <name><surname>Warren</surname><given-names>JC</given-names></name>, <etal/>
<article-title>Development of an easy to use tool to assess HIV treatment
readiness in adolescent clinical care settings</article-title>. <source>AIDS Care</source>.
<year>2011</year>;<volume>23</volume>(<issue>11</issue>):<fpage>1492</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">22022853</pub-id>
</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>Mansergh</surname><given-names>G</given-names></name>, <name><surname>Kota</surname><given-names>KK</given-names></name>, <name><surname>Carnes</surname><given-names>N</given-names></name>, <name><surname>Gelaude</surname><given-names>D</given-names></name>. <article-title>Brief report: refusal of daily oral PrEP: implementation
considerations and reported likelihood of using various HIV prophylaxis
products in a diverse sample of MSM</article-title>. <source>J Acquir Immune Defic Syndr</source>.
<year>2023</year>;<volume>92</volume>(<issue>3</issue>):<fpage>212</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">36442153</pub-id>
</mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><name><surname>Kamitani</surname><given-names>E</given-names></name>, <name><surname>Higa</surname><given-names>DH</given-names></name>, <name><surname>Crepaz</surname><given-names>N</given-names></name>, <etal/>
<article-title>Identifying Best Practices for Increasing HIV Pre-exposure
Prophylaxis (PrEP) Use and Persistence in the United States: A Systematic
Review</article-title>. <source>AIDS Behav</source>. <pub-id pub-id-type="doi">10.1007/s10461-024-04332-z</pub-id>.
<comment>Advance online publication.</comment>
</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Newman</surname><given-names>R</given-names></name>, <name><surname>Katchi</surname><given-names>T</given-names></name>, <name><surname>Karass</surname><given-names>M</given-names></name>, <etal/>
<article-title>Enhancing HIV pre-exposure prophylaxis practices via an
educational intervention</article-title>. <source>Am J Ther</source>.
<year>2019</year>;<volume>26</volume>:<fpage>e462</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">29683840</pub-id>
</mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>YA</given-names></name>, <name><surname>Zhu</surname><given-names>W</given-names></name>, <name><surname>Smith</surname><given-names>DK</given-names></name>, <etal/>
<article-title>HIV Preexposure Prophylaxis, by Race and Ethnicity &#x02014;
United States, 2014&#x02013;2016</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>.
<year>2018</year>;<volume>67</volume>:<fpage>1147</fpage>&#x02013;<lpage>1150</lpage>.<pub-id pub-id-type="pmid">30335734</pub-id>
</mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Fauci</surname><given-names>AS</given-names></name>, <name><surname>Redfield</surname><given-names>RR</given-names></name>, <name><surname>Sigounas</surname><given-names>G</given-names></name>, <etal/>
<article-title>Ending the HIV Epidemic: A Plan for the United
States</article-title>. <source>JAMA</source>.
<year>2019</year>;<volume>321</volume>(<issue>9</issue>):<fpage>844</fpage>&#x02013;<lpage>85</lpage><pub-id pub-id-type="pmid">30730529</pub-id>
</mixed-citation></ref></ref-list></back><floats-group><table-wrap position="float" id="T1" orientation="landscape"><label>Table 1.</label><caption><p id="P28">Characteristics and readiness for PrEP among GBMSM who were not recently
offered PrEP by a provider, in Atlanta, Georgia, Chicago, Illinois, and
Raleigh-Durham, North Carolina, US, 2019 (n=187).</p></caption><table frame="below" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="5" align="left" valign="top" style="border-bottom: solid 1px" rowspan="1">
<italic toggle="yes">Ready to&#x02026;</italic>
</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">Discuss PrEP</th><th align="left" valign="top" rowspan="1" colspan="1">HIV Testing</th><th align="left" valign="top" rowspan="1" colspan="1">Take Daily Pill</th><th align="left" valign="top" rowspan="1" colspan="1">Appointments</th><th align="left" valign="top" rowspan="1" colspan="1">Full Regimen</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">n (%)</th><th align="left" valign="top" rowspan="1" colspan="1">n (%)</th><th align="left" valign="top" rowspan="1" colspan="1">n (%)</th><th align="left" valign="top" rowspan="1" colspan="1">n (%)</th><th align="left" valign="top" rowspan="1" colspan="1">n (%)</th><th align="left" valign="top" rowspan="1" colspan="1">n (%)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Total</td><td align="left" valign="top" rowspan="1" colspan="1">187 (100)</td><td align="left" valign="top" rowspan="1" colspan="1">102 (55)</td><td align="left" valign="top" rowspan="1" colspan="1">164 (88)</td><td align="left" valign="top" rowspan="1" colspan="1">85 (45)</td><td align="left" valign="top" rowspan="1" colspan="1">90 (48)</td><td align="left" valign="top" rowspan="1" colspan="1">70 (37)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Race and Ethnicity</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Non-Hispanic Black/African
American</td><td align="left" valign="top" rowspan="1" colspan="1">95 (51)</td><td align="left" valign="top" rowspan="1" colspan="1">53 (56)</td><td align="left" valign="top" rowspan="1" colspan="1">82 (86)</td><td align="left" valign="top" rowspan="1" colspan="1">45 (47)</td><td align="left" valign="top" rowspan="1" colspan="1">49 (52)</td><td align="left" valign="top" rowspan="1" colspan="1">41 (43)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Hispanic/Latino</td><td align="left" valign="top" rowspan="1" colspan="1">28 (15)</td><td align="left" valign="top" rowspan="1" colspan="1">14 (50)</td><td align="left" valign="top" rowspan="1" colspan="1">25 (89)</td><td align="left" valign="top" rowspan="1" colspan="1">11 (39)</td><td align="left" valign="top" rowspan="1" colspan="1">12 (43)</td><td align="left" valign="top" rowspan="1" colspan="1">9 (32)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Non-Hispanic White/other</td><td align="left" valign="top" rowspan="1" colspan="1">62 (34)</td><td align="left" valign="top" rowspan="1" colspan="1">34 (55)</td><td align="left" valign="top" rowspan="1" colspan="1">55 (89)</td><td align="left" valign="top" rowspan="1" colspan="1">28 (45)</td><td align="left" valign="top" rowspan="1" colspan="1">28 (45)</td><td align="left" valign="top" rowspan="1" colspan="1">19 (31)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age group, years</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;18&#x02013;25</td><td align="left" valign="top" rowspan="1" colspan="1">59 (31)</td><td align="left" valign="top" rowspan="1" colspan="1">33 (56)</td><td align="left" valign="top" rowspan="1" colspan="1">51 (86)</td><td align="left" valign="top" rowspan="1" colspan="1">26 (44)</td><td align="left" valign="top" rowspan="1" colspan="1">27 (46)</td><td align="left" valign="top" rowspan="1" colspan="1">20 (34)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;26&#x02013;35</td><td align="left" valign="top" rowspan="1" colspan="1">76 (41)</td><td align="left" valign="top" rowspan="1" colspan="1">41 (54)</td><td align="left" valign="top" rowspan="1" colspan="1">70 (92)</td><td align="left" valign="top" rowspan="1" colspan="1">35 (46)</td><td align="left" valign="top" rowspan="1" colspan="1">37 (49)</td><td align="left" valign="top" rowspan="1" colspan="1">31 (41)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;36+</td><td align="left" valign="top" rowspan="1" colspan="1">52 (28)</td><td align="left" valign="top" rowspan="1" colspan="1">28 (54)</td><td align="left" valign="top" rowspan="1" colspan="1">43 (83)</td><td align="left" valign="top" rowspan="1" colspan="1">24 (46)</td><td align="left" valign="top" rowspan="1" colspan="1">26 (50)</td><td align="left" valign="top" rowspan="1" colspan="1">19 (37)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Education level</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x0003c;=HS Diploma/GED</td><td align="left" valign="top" rowspan="1" colspan="1">58 (31)</td><td align="left" valign="top" rowspan="1" colspan="1">32 (55)</td><td align="left" valign="top" rowspan="1" colspan="1">49 (84)</td><td align="left" valign="top" rowspan="1" colspan="1">28 (48)</td><td align="left" valign="top" rowspan="1" colspan="1">34 (59)</td><td align="left" valign="top" rowspan="1" colspan="1">25 (43)<xref rid="TFN1" ref-type="table-fn">*</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Some post HS training</td><td align="left" valign="top" rowspan="1" colspan="1">49 (26)</td><td align="left" valign="top" rowspan="1" colspan="1">30 (61)</td><td align="left" valign="top" rowspan="1" colspan="1">44 (90)</td><td align="left" valign="top" rowspan="1" colspan="1">28 (57)</td><td align="left" valign="top" rowspan="1" colspan="1">26 (53)</td><td align="left" valign="top" rowspan="1" colspan="1">24 (50)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x0003e;=4-year college degree</td><td align="left" valign="top" rowspan="1" colspan="1">78 (42)</td><td align="left" valign="top" rowspan="1" colspan="1">40 (51)</td><td align="left" valign="top" rowspan="1" colspan="1">69 (88)</td><td align="left" valign="top" rowspan="1" colspan="1">29 (37)</td><td align="left" valign="top" rowspan="1" colspan="1">30 (38)</td><td align="left" valign="top" rowspan="1" colspan="1">21 (27)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Self-identification</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Gay</td><td align="left" valign="top" rowspan="1" colspan="1">130 (70)</td><td align="left" valign="top" rowspan="1" colspan="1">78 (60)<xref rid="TFN1" ref-type="table-fn">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">118 (91)<xref rid="TFN1" ref-type="table-fn">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">62 (48)</td><td align="left" valign="top" rowspan="1" colspan="1">66 (51)</td><td align="left" valign="top" rowspan="1" colspan="1">51 (39)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Bisexual or Straight</td><td align="left" valign="top" rowspan="1" colspan="1">55 (30)</td><td align="left" valign="top" rowspan="1" colspan="1">23 (42)</td><td align="left" valign="top" rowspan="1" colspan="1">44 (80)</td><td align="left" valign="top" rowspan="1" colspan="1">22 (40)</td><td align="left" valign="top" rowspan="1" colspan="1">22 (40)</td><td align="left" valign="top" rowspan="1" colspan="1">18 (33)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Health Insurance Coverage</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes</td><td align="left" valign="top" rowspan="1" colspan="1">130 (71)</td><td align="left" valign="top" rowspan="1" colspan="1">66 (51)</td><td align="left" valign="top" rowspan="1" colspan="1">116 (89)</td><td align="left" valign="top" rowspan="1" colspan="1">50 (38)<xref rid="TFN1" ref-type="table-fn">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">56 (43)<xref rid="TFN1" ref-type="table-fn">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">40 (31)<xref rid="TFN1" ref-type="table-fn">*</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No</td><td align="left" valign="top" rowspan="1" colspan="1">52 (29)</td><td align="left" valign="top" rowspan="1" colspan="1">34 (65)</td><td align="left" valign="top" rowspan="1" colspan="1">45 (87)</td><td align="left" valign="top" rowspan="1" colspan="1">33 (63)</td><td align="left" valign="top" rowspan="1" colspan="1">31 (60)</td><td align="left" valign="top" rowspan="1" colspan="1">28 (54)</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>*</label><p id="P29">p &#x0003c; 0.05; HS - high school; GED - general education degree;
AOR - adjusted odds ratio; CI - confidence interval</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2" orientation="landscape"><label>Table 2.</label><caption><p id="P30">Multivariable Analysis of Characteristics Associated with Readiness for
PrEP among GBMSM, in Atlanta, Georgia, Chicago, Illinois, and Raleigh-Durham,
North Carolina, US, 2019 (n=187).</p></caption><table frame="below" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="5" align="left" valign="top" style="border-bottom: solid 1px" rowspan="1">
<italic toggle="yes">Ready to &#x02026;</italic>
</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">Discuss PrEP</th><th align="left" valign="top" rowspan="1" colspan="1">HIV Testing</th><th align="left" valign="top" rowspan="1" colspan="1">Take Daily Pill</th><th align="left" valign="top" rowspan="1" colspan="1">Appointments</th><th align="left" valign="top" rowspan="1" colspan="1">Full Regimen</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">AOR (95% CI)</th><th align="left" valign="top" rowspan="1" colspan="1">AOR (95% CI)</th><th align="left" valign="top" rowspan="1" colspan="1">AOR (95% CI)</th><th align="left" valign="top" rowspan="1" colspan="1">AOR (95% CI)</th><th align="left" valign="top" rowspan="1" colspan="1">AOR (95% CI)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Race and Ethnicity</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Non-Hispanic White/other
(reference)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Non-Hispanic Black/African
American</td><td align="left" valign="top" rowspan="1" colspan="1">1.08 (0.51&#x02013;2.30)</td><td align="left" valign="top" rowspan="1" colspan="1">0.97 (0.31&#x02013;3.11)</td><td align="left" valign="top" rowspan="1" colspan="1">0.82 (0.38&#x02013;1.76)</td><td align="left" valign="top" rowspan="1" colspan="1">0.93 (0.44&#x02013;1.98)</td><td align="left" valign="top" rowspan="1" colspan="1">1.29 (0.58&#x02013;2.85)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Hispanic/Latino</td><td align="left" valign="top" rowspan="1" colspan="1">0.79 (0.31&#x02013;2.01)</td><td align="left" valign="top" rowspan="1" colspan="1">1.09 (0.25&#x02013;4.77)</td><td align="left" valign="top" rowspan="1" colspan="1">0.68 (0.26&#x02013;1.79)</td><td align="left" valign="top" rowspan="1" colspan="1">0.79 (0.31&#x02013;2.03)</td><td align="left" valign="top" rowspan="1" colspan="1">0.95 (0.35&#x02013;2.63)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age group</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;36+ years (reference)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;18&#x02013;25 years</td><td align="left" valign="top" rowspan="1" colspan="1">1.00 (0.45&#x02013;2.24)</td><td align="left" valign="top" rowspan="1" colspan="1">1.48 (0.49&#x02013;4.45)</td><td align="left" valign="top" rowspan="1" colspan="1">0.81 (0.36&#x02013;1.84)</td><td align="left" valign="top" rowspan="1" colspan="1">0.81 (0.36&#x02013;1.82)</td><td align="left" valign="top" rowspan="1" colspan="1">0.75 (0.32&#x02013;1.76)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;26&#x02013;35 years</td><td align="left" valign="top" rowspan="1" colspan="1">0.87 (0.41&#x02013;1.87)</td><td align="left" valign="top" rowspan="1" colspan="1">2.73 (0.83&#x02013;8.95)</td><td align="left" valign="top" rowspan="1" colspan="1">0.98 (0.45&#x02013;2.11)</td><td align="left" valign="top" rowspan="1" colspan="1">0.90 (0.42&#x02013;1.93)</td><td align="left" valign="top" rowspan="1" colspan="1">1.18 (0.53&#x02013;2.62)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Education level</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003; &#x0003e;=4yr Degree (reference)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;HSDiplomaGED</td><td align="left" valign="top" rowspan="1" colspan="1">1.19 (0.35&#x02013;2.68)</td><td align="left" valign="top" rowspan="1" colspan="1">1.12 (0.33&#x02013;3.81)</td><td align="left" valign="top" rowspan="1" colspan="1">1.49 (0.65&#x02013;3.40)</td><td align="left" valign="top" rowspan="1" colspan="1">2.19 (0.97&#x02013;4.95)</td><td align="left" valign="top" rowspan="1" colspan="1">1.73 (0.74&#x02013;4.06)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Some post HS training</td><td align="left" valign="top" rowspan="1" colspan="1">1.33 (0.61&#x02013;2.89)</td><td align="left" valign="top" rowspan="1" colspan="1">1.09 (0.32&#x02013;3.66)</td><td align="left" valign="top" rowspan="1" colspan="1">2.19 (0.99&#x02013;4.83)</td><td align="left" valign="top" rowspan="1" colspan="1">1.70 (0.78&#x02013;3.70)</td><td align="left" valign="top" rowspan="1" colspan="1">2.34 (1.04&#x02013;5.29)<xref rid="TFN2" ref-type="table-fn">*</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Self-identification</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Bisexual or Straight (reference)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Gay</td><td align="left" valign="top" rowspan="1" colspan="1">2.14 (1.05&#x02013;4.36)<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">1.73 (0.64&#x02013;4.66)</td><td align="left" valign="top" rowspan="1" colspan="1">1.37 (0.66&#x02013;2.81)</td><td align="left" valign="top" rowspan="1" colspan="1">1.78 (0.86&#x02013;3.65)</td><td align="left" valign="top" rowspan="1" colspan="1">1.40 (0.66&#x02013;2.96)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Health Insurance</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes (reference)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No</td><td align="left" valign="top" rowspan="1" colspan="1">1.84 (0.88&#x02013;3.83)</td><td align="left" valign="top" rowspan="1" colspan="1">0.88 (0.31&#x02013;2.56)</td><td align="left" valign="top" rowspan="1" colspan="1">2.78 (1.34&#x02013;5.78)<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">1.72 (0.84&#x02013;3.52)</td><td align="left" valign="top" rowspan="1" colspan="1">2.34 (1.13&#x02013;4.85)<xref rid="TFN2" ref-type="table-fn">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><label>*</label><p id="P31">p &#x0003c; 0.05; HS -high school; GED - general education degree;
AOR - adjusted odds ratio; CI - confidence interval</p></fn></table-wrap-foot></table-wrap></floats-group></article>